Here is the AI research roadmap for 2026: how agents that learn, self-correct, and simulate the real world will redefine ...

The reported valuation aligns with where Manus had been headed before Meta intervened. The company had been raising new funds ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

AI use in Kurdistan is surging, aiding youth employment and trade, but experts warn of privacy risks and future self-teaching ...

Recursion Pharmaceuticals (NASDAQ: RXRX), a small-cap biotech company, has one claim to fame: It currently owns the largest ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

When security vulnerabilities appear in popular frameworks, they can affect thousands of websites overnight. That’s exactly what’s happening with a newly discovered vulnerability in Next.js – one of ...